College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, 22490, Riyadh, Saudi Arabia.
King Abdullah International Medical Research Center, Riyadh, 11481, Saudi Arabia.
BMC Endocr Disord. 2022 Jun 9;22(1):155. doi: 10.1186/s12902-022-01059-7.
Primary hyperparathyroidism (PHPT) is a common cause of hypercalcemia and remains understudied within the Arabian population. The present study, the largest of its kind within the Gulf Cooperation Council (GCC) countries, aims to determine the demographics and clinical presentation of PHPT in Saudi Arabia.
In this multi-center retrospective study involving three tertiary hospitals in different geographic locations of Saudi Arabia namely, Riyadh, Al Ahsa and Jeddah, a total of 205 out of 243 confirmed PHPT cases aged 16 to 93 years old were included (N = 96 from Riyadh; N = 59 from Al Ahsa and N = 50 from Jeddah). Demographics, clinical manifestations and surgical outcomes were recorded as well as laboratory and radiologic investigations including serum parathyroid hormone (PTH), 25(OH)D, adjusted calcium, estimated glomerular filtration rate (eGFR) and nuclear scan outcome.
PHPT cases appeared to increase over time when compared to other local studies published so far, with 12.8 cases per 100,000 hospital population. Females outnumber males (3:1) with 86% seen as out-patients. The average age was 59.8 ± 15.5 years. Abnormal PTH scan was seen in 171 patients (83.4%). Kidney stones was the most common renal manifestation (32 cases, 15.6%) and osteoporosis was the most common skeletal manifestation (67 cases, 32.7%). Al Ahsa had the highest prevalence of multiple comorbidities at 54% and the highest prevalence of obesity as a single comorbidity (17%) compared to other regions (p < 0.05). Jeddah recorded the highest prevalence of osteoporosis with bone and joint pains (30%) (p < 0.05).
Comparison of present data with previous local studies suggest an increasing trend in PHPT cases in Saudi Arabia. Regional variations in the clinical presentation of PHPT were observed and warrant further investigation.
甲状旁腺功能亢进症(PHPT)是高钙血症的常见原因,在阿拉伯人群中的研究仍不够充分。本研究是海湾合作委员会(GCC)国家中此类研究中规模最大的一项,旨在确定沙特阿拉伯 PHPT 的人口统计学和临床表现。
在这项涉及沙特阿拉伯三个不同地理位置的三级医院的多中心回顾性研究中,共纳入了 243 例确诊 PHPT 患者中的 205 例(年龄 16 至 93 岁,N=96 例来自利雅得;N=59 例来自阿哈萨;N=50 例来自吉达)。记录了人口统计学、临床表现和手术结果,以及实验室和影像学检查,包括血清甲状旁腺激素(PTH)、25(OH)D、校正钙、估算肾小球滤过率(eGFR)和核扫描结果。
与迄今为止发表的其他本地研究相比,PHPT 病例似乎呈上升趋势,每 100,000 例住院患者中有 12.8 例。女性多于男性(3:1),86%为门诊患者。平均年龄为 59.8±15.5 岁。171 例患者(83.4%)甲状旁腺激素扫描异常。肾结石是最常见的肾脏表现(32 例,15.6%),骨质疏松症是最常见的骨骼表现(67 例,32.7%)。与其他地区相比,阿哈萨的合并症发生率最高(54%),肥胖的单一合并症发生率最高(17%)(p<0.05)。吉达记录了骨质疏松症伴骨和关节疼痛的最高患病率(30%)(p<0.05)。
将目前的数据与以前的本地研究进行比较,表明沙特阿拉伯 PHPT 病例呈上升趋势。观察到 PHPT 临床表现的区域差异,需要进一步调查。